Saurabh Bharti
Overview
Explore the profile of Saurabh Bharti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rani N, Bharti S, Tomar A, Dinda A, Arya D, Bhatia J
Free Radic Res
. 2016 Aug;
50(11):1226-1236.
PMID: 27571604
Oxidative stress-induced PARP activation has been recognized to be a main factor in the pathogenesis of cisplatin-induced nephrotoxicity. Accumulating literature has revealed that ACE inhibitors may exert beneficial effect in...
2.
Rani N, Bharti S, Krishnamurthy B, Bhatia J, Sharma C, Kamal M, et al.
Curr Pharm Des
. 2016 May;
22(28):4341-59.
PMID: 27238365
Naringenin chemically known as 5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one is a common dietary polyphenolic constituent of the citrus fruits. It has received considerable attention for pharmaceutical and nutritional development due to potent pharmacological activities...
3.
Rani N, Bharti S, Bhatia J, Nag T, Ray R, Arya D
Chem Biol Interact
. 2016 Mar;
250:59-67.
PMID: 26972669
AGE-RAGE interaction mediated oxidative stress and inflammation is the key mechanism involved in the pathogenesis of cardiovascular disease in diabetes. Inhibition of AGE-RAGE axis by several PPAR-γ agonists has shown...
4.
Krishnamurthy B, Rani N, Bharti S, Golechha M, Bhatia J, Nag T, et al.
Chem Biol Interact
. 2015 Jun;
237:96-103.
PMID: 26036690
The clinical use of doxorubicin is associated with dose limiting cardiotoxicity. This is a manifestation of free radical production triggered by doxorubicin. Therefore, we evaluated the efficacy of febuxostat, a...
5.
Rani N, Bharti S, Bhatia J, Tomar A, Nag T, Ray R, et al.
Nutr Metab (Lond)
. 2015 Mar;
12:11.
PMID: 25774203
Background: Pharmacological stimulation of peroxisome proliferator-activated receptor-gamma (PPAR-γ) has been recognized as a molecular switch in alleviating myocardial injury through modulating oxidative, inflammatory and apoptotic signaling pathways. This study was...
6.
Bharti S, Rani N, Bhatia J, Arya D
Apoptosis
. 2014 Dec;
20(4):455-65.
PMID: 25544272
Recent studies have proposed the potential role of 5-HT2B receptor (5-HT2BR) blockade in alleviating myocardial dysfunction; hitherto, the regulatory pathway for its protective effect has remained enigmatic. In the present...
7.
Bhatia J, Gamad N, Bharti S, Arya D
World J Diabetes
. 2014 Jun;
5(3):399-406.
PMID: 24936262
Canagliflozin (CFZ) is a member of new class of glucose lowering agents, sodium-glucose co-transporter (SGLT) inhibitors, which got approval by food and drug administration. It has insulin independent action by...
8.
Bharti S, Rani N, Krishnamurthy B, Arya D
Planta Med
. 2014 Apr;
80(6):437-51.
PMID: 24710903
Naringin, chemically 4',5,7- trihydroxyflavanone-7-rhamnoglucoside, is a major flavanone glycoside obtained from tomatoes, grapefruits, and many other citrus fruits. It has been experimentally documented to possess numerous biological properties such as...
9.
Rani N, Bharti S, Manchanda M, Nag T, Ray R, Chauhan S, et al.
PLoS One
. 2013 Dec;
8(12):e82577.
PMID: 24324809
Naringin has antioxidant properties that could improve redox-sensitive myocardial ischemia reperfusion (IR) injury. This study was designed to investigate whether naringin restores the myocardial damage and dysfunction in vivo after...
10.
Krishnamurthy B, Bharti S, Guleria R, Arya D
Exp Toxicol Pathol
. 2012 Nov;
65(5):709-10.
PMID: 23182964
No abstract available.